High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints

MA Lisio, L Fu, A Goyeneche, Z Gao… - International journal of …, 2019 - mdpi.com
Among a litany of malignancies affecting the female reproductive tract, that of the ovary is the
most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled …

Cell origins of high-grade serous ovarian cancer

J Kim, EY Park, O Kim, JM Schilder, DM Coffey… - Cancers, 2018 - mdpi.com
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is
the most common and deadliest type of ovarian cancer. HGSC appears to arise from the …

Dissecting metastasis using preclinical models and methods

JD Hebert, JW Neal, MM Winslow - Nature Reviews Cancer, 2023 - nature.com
Metastasis has long been understood to lead to the overwhelming majority of cancer-related
deaths. However, our understanding of the metastatic process, and thus our ability to …

Pathogenesis and heterogeneity of ovarian cancer

PT Kroeger Jr, R Drapkin - Current Opinion in Obstetrics and …, 2017 - journals.lww.com
The fallopian tube secretory cell is the cell of origin for the majority of ovarian cancers.
Although it remains unclear what triggers neoplastic transformation of these cells, certain …

PTEN: multiple functions in human malignant tumors

M Milella, I Falcone, F Conciatori, U Cesta Incani… - Frontiers in …, 2015 - frontiersin.org
PTEN is the most important negative regulator of the PI3K signaling pathway. In addition to
its canonical, PI3K inhibition-dependent functions, PTEN can also function as a tumor …

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca; Tp53; Pten models

R Perets, GA Wyant, KW Muto, JG Bijron, BB Poole… - Cancer cell, 2013 - cell.com
High-grade serous ovarian carcinoma presents significant clinical and therapeutic
challenges. Although the traditional model of carcinogenesis has focused on the ovary as a …

Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells

U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi - Medicines, 2018 - mdpi.com
Four main histological subtypes of ovarian cancer exist: serous (the most frequent),
endometrioid, mucinous and clear cell; in each subtype, low and high grade. The large …

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma

J Ducie, F Dao, M Considine, N Olvera… - Nature …, 2017 - nature.com
Many high-grade serous carcinomas (HGSCs) of the pelvis are thought to originate in the
distal portion of the fallopian tube. Serous tubal intra-epithelial carcinoma (STIC) lesions are …

Biology-driven therapy advances in high-grade serous ovarian cancer

Y Wang, AJ Duval, M Adli, D Matei - The Journal of Clinical …, 2024 - Am Soc Clin Investig
Following a period of slow progress, the completion of genome sequencing and the
paradigm shift relative to the cell of origin for high grade serous ovarian cancer (HGSOC) led …

Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy

S Iyer, S Zhang, S Yucel, H Horn, SG Smith… - Cancer Discovery, 2021 - AACR
Despite advances in immuno-oncology, the relationship between tumor genotypes and
response to immunotherapy remains poorly understood, particularly in high-grade serous …